Form D · Biotechnology

CancerVAX, Inc.

Santa Barbara, CA · CIK 0001905495

Offering snapshot reported Oct 18, 2024 · SEC filing

Reported sold
$1M
Offering amount: $10M
Investors reported
1
Form D · investor count
Minimum accepted
$100K
Reported outside-investor minimum
First sale
Oct 13, 2023
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$500K$1MOct 26, 2023: $500,000.00Oct 26, 2023Oct 18, 2024: $1,000,000.00Oct 18, 2024

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$500,000 → $1,000,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 18, 2024Amendment$1,000,000$500,000vs Oct 26, 20231SEC filing
Oct 26, 2023Initial$500,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-495745

Source: Form D, filed Oct 18, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Ryan Davies Director, Executive
Byron Elton Director, Executive
Carla Miller Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
351 Paseo Nuevo Floor 2
Santa Barbara, CA, 93101